semaglutide blood test GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters Blood Tests Before Semaglutide |

This study is examining weight loss, appetite suppression, and HbA1C changes, which are the primary outcomes of interest for a GLP-1 agonist

Diagnosis and Medical History: Primary diagnosis (e.g., Type 2 Diabetes, Obesity) with ICD-10 codes

HbA 1c and weight outcomes were assessed for those in the T2D cohort

No custom code was generated for data analyses in this study

Compared with active drugs, oral semaglutide was superior to empagliflozin in reducing total cholesterol and LDL [36] and was superior to sitagliptin in reducing total cholesterol, LDL, and TAGs [37, 41], but there was no significant difference when compared with another GLP-1 analogue (liraglutide) [38]

Your PlexusDx provider can adjust your dose strategy if needed to support continued progress